|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effective Protection of Open Space: does planning matter?显示文摘 | Toddi A Steelman George R Hess | 2009 | Environmental Management2009，44，： | 1 |
| 2 | Just What is Sprawl Anyway?显示文摘 | George R Hess | 2001 | Carolina Planning2001，，26： | 1 |
| 3 | The effect of RAAS blockade on markers of renal tubular damage in diabetic nephropathy: u-NGAL, u-KIM1 and u-LFABP显示文摘 | Stine E. Nielsen Kasper Rossing Georg Hess Dietmar Zdunek Berit R. Jensen Hans-Henrik Parving Peter Rossing | 2012 | Scandinavian Journal of Clinical & Laboratory Investigation2012，，2： | 1 |
| 4 | Primary adenocarcinoma of the duodenum: Management and survival in 67 patients显示文摘 | George Barnes MD Lucinda Romero MD Kenneth R. Hess PhD Steven A. Curley MD | 1994 | Annals of Surgical Oncology1994，，1： | 1 |
| 5 | Microvillus Inclusion Disease: Loss of Myosin Vb Disrupts Intracellular Traffic and Cell Polarity显示文摘 | Cornelia E. Thoeni Georg F. Vogel Ivan Tancevski Stephan Geley Silvia Lechner Kristian Pfaller Michael W. Hess Thomas Müller Andreas R. Janecke Yaron Avitzur Aleixo Muise Ernest Cutz Lukas A. Huber | 2014 | Traffic2014，，1： | 1 |
| 6 | Cis-antisense RNA,another level of gene regulation in bacteria显示文摘 | Georg J Hess W R | 2011 | Microbiol Mol Bio Rev2011，75，2： | 1 |
| 7 | Communicating clearly about conservation corridors显示文摘 | George R. Hess Richard A. Fischer | 2001 | Landscape and Urban Planning2001，，3： | 1 |
| 8 | Biomim- etie synthesis of polyeyclie polyprenylated acylphloro- glucinol natural products isolated from hypericum pap- uanum 显示文摘 | J H George M D Hesse J E Baldwin eta/ | 2010 | Org Lett2010，12，： | 1 |
| 9 | Primary adenocarcinoma of the duodenum: Management and survival in 67 patients显示文摘 | George Barnes MD Lucinda Romero MD Kenneth R. Hess PhD Steven A. Curley MD | 1994 | Annals of Surgical Oncology1994，，1： | 1 |
| 10 | The effect of RAAS blockade on markers of renal tubular damage in diabetic nephropathy: u-NGAL, u-KIM1 and u-LFABP显示文摘 | Stine E. Nielsen Kasper Rossing Georg Hess Dietmar Zdunek Berit R. Jensen Hans-Henrik Parving Peter Rossing | 2012 | Scandinavian Journal of Clinical & Laboratory Investigation2012，，2： | 1 |
| 11 | Cloning and characterization of a cDNA encoding a cobalamin-independent methionine synthase from potato (Solanum tuberosum L.)显示文摘 | Michaela Zeh Georg Leggewie Rainer Hoefgen Holger Hesse | 2002 | Plant Molecular Biology2002，，3： | 1 |
| 12 | Mammalian nest predators respond to greenway width, landscape context and habitat structure显示文摘 | Kristen E. Sinclair George R. Hess Christopher E. Moorman Jamie H. Mason | 2004 | Landscape and Urban Planning2004，，2： | 1 |
| 13 | Elevated plasma levels of N-terminal pro-brain natriuretic peptide in patients with chronic hepatitis C during interferon-based antiviral therapy显示文摘AIM: To investigate plasma levels of N-terminal pro-brain natriuretic peptide (NT-proBNP), an established marker of cardiac function, in patients with chronic hepatitis C during interferon-based antiviral therapy. METHODS: Using a sandwich immunoassay, plasma levels of NT-proBNP were determined in 48 patients with chronic hepatitis C at baseline, wk 24 and 48 during antiviral therapy and at wk 72 during follow-up.RESULTS: Plasma NT-proBNP concentrations were significantly increased (P < 0.05) at wk 24, 48 and 72 compared to the baseline values. NT-proBNP concentrations at baseline and wk 24 were closely correlated (r = 0.8; P < 0.001). At wk 24, 7 (14.6%) patients had NT-proBNP concentrations above 200 ng/L compared to 1 (2%) patient at baseline (P = 0.059). Six of these 7 patients had been treated with high-dose IFN-α induction therapy. In multiple regression analysis, NT-proBNP was not related to other clinical parameters, biochemical parameters of liver disease or virus load and response to therapy.CONCLUSION: Elevated levels of NT-proBNP during and after interferon-based antiviral therapy of chronic hepatitis C may indicate the presence of cardiac dysfunction, which may contribute to the clinical symptoms observed in patients during therapy. Plasma levels of NT-proBNP may be used as a diagnostic tool and for guiding therapy in patients during interferon-based antiviral therapy. | Jrg Bojunga Christoph Sarrazin Georg Hess Stefan Zeuzem | 2006 | World Journal of Gastroenterology2006，12，36： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员